135 related articles for article (PubMed ID: 35504365)
21. SECOND CANCER RISK FROM RADIATION THERAPY FOR COMMON SOLID TUMORS DIAGNOSED IN REPRODUCTIVE-AGED FEMALES.
Mazonakis M; Kachris S; Damilakis J
Radiat Prot Dosimetry; 2018 Dec; 182(2):208-214. PubMed ID: 29608744
[TBL] [Abstract][Full Text] [Related]
22. Probability of carcinogenesis due to involved field and involved site radiation therapy techniques for supra- and infradiaphragmatic Hodgkin's disease.
Kourinou KM; Mazonakis M; Lyraraki E; Papadaki HΑ; Damilakis J
Phys Med; 2019 Jan; 57():100-106. PubMed ID: 30738513
[TBL] [Abstract][Full Text] [Related]
23. The role of Size-Specific Dose Estimate (SSDE) in patient-specific organ dose and cancer risk estimation in paediatric chest and abdominopelvic CT examinations.
Franck C; Vandevoorde C; Goethals I; Smeets P; Achten E; Verstraete K; Thierens H; Bacher K
Eur Radiol; 2016 Aug; 26(8):2646-55. PubMed ID: 26670320
[TBL] [Abstract][Full Text] [Related]
24. Comparison of whole-body phantom designs to estimate organ equivalent neutron doses for secondary cancer risk assessment in proton therapy.
Moteabbed M; Geyer A; Drenkhahn R; Bolch WE; Paganetti H
Phys Med Biol; 2012 Jan; 57(2):499-515. PubMed ID: 22217682
[TBL] [Abstract][Full Text] [Related]
25. The risk of induced cancer and ischemic heart disease following low dose lung irradiation for COVID-19: estimation based on a virtual case.
Arruda GV; Weber RRDS; Bruno AC; Pavoni JF
Int J Radiat Biol; 2021; 97(2):120-125. PubMed ID: 33164596
[TBL] [Abstract][Full Text] [Related]
26. Out-of-field doses from secondary radiation produced in proton therapy and the associated risk of radiation-induced cancer from a brain tumor treatment.
Ardenfors O; Dasu A; Lillhök J; Persson L; Gudowska I
Phys Med; 2018 Sep; 53():129-136. PubMed ID: 30241747
[TBL] [Abstract][Full Text] [Related]
27. Introduction of a method to calculate cumulative age- and gender-specific lifetime attributable risk (LAR) of cancer in populations after a large-scale nuclear power plant accident.
Rääf C; Markovic N; Tondel M; Wålinder R; Isaksson M
PLoS One; 2020; 15(2):e0228549. PubMed ID: 32023299
[TBL] [Abstract][Full Text] [Related]
28. Out-of-field doses for scanning proton radiotherapy of shallowly located paediatric tumours-a comparison of range shifter and 3D printed compensator.
Wochnik A; Stolarczyk L; Ambrožová I; Davídková M; De Saint-Hubert M; Domański S; Domingo C; Knežević Ž; Kopeć R; Kuć M; Majer M; Mojżeszek N; Mares V; Martínez-Rovira I; Caballero-Pacheco MÁ; Pyszka E; Swakoń J; Trinkl S; Tisi M; Harrison R; Olko P
Phys Med Biol; 2021 Jan; 66(3):035012. PubMed ID: 33202399
[TBL] [Abstract][Full Text] [Related]
29. Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk.
Filippi AR; Ragona R; Piva C; Scafa D; Fiandra C; Fusella M; Giglioli FR; Lohr F; Ricardi U
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):161-8. PubMed ID: 25863763
[TBL] [Abstract][Full Text] [Related]
30. Evaluating out-of-field doses during radiotherapy of paediatric brain tumours using lead shielding and flattening-filter free beams.
Beierholm AR; Nygaard DE; Juhl EL; Hansen R; Hansen J
Phys Med; 2019 Apr; 60():1-6. PubMed ID: 31000068
[TBL] [Abstract][Full Text] [Related]
31. Risk of radiation-induced second malignant neoplasms from photon and proton radiotherapy in paediatric abdominal neuroblastoma.
Taylor S; Lim P; Ahmad R; Alhadi A; Harris W; Rompokos V; D'Souza D; Gaze M; Gains J; Veiga C
Phys Imaging Radiat Oncol; 2021 Jul; 19():45-52. PubMed ID: 34307918
[TBL] [Abstract][Full Text] [Related]
32. Complete patient exposure during paediatric brain cancer treatment for photon and proton therapy techniques including imaging procedures.
De Saint-Hubert M; Boissonnat G; Schneider U; Bäumer C; Verbeek N; Esser J; Wulff J; Stuckmann F; Suesselbeck F; Nabha R; Dabin J; Vasi F; Radonic S; Rodriguez M; Simon AC; Journy N; Timmermann B; Thierry-Chef I; Brualla L
Front Oncol; 2023; 13():1222800. PubMed ID: 37795436
[TBL] [Abstract][Full Text] [Related]
33. Estimating the second primary cancer risk due to proton therapy compared to hybrid IMRT for left sided breast cancer.
Santos AMC; Kotsanis A; Cunningham L; Penfold SN
Acta Oncol; 2021 Mar; 60(3):300-304. PubMed ID: 33345660
[TBL] [Abstract][Full Text] [Related]
34. Estimation of second cancer risk after radiotherapy for rectal cancer: comparison of 3D conformal radiotherapy and volumetric modulated arc therapy using different high dose fractionation schemes.
Zwahlen DR; Bischoff LI; Gruber G; Sumila M; Schneider U
Radiat Oncol; 2016 Nov; 11(1):149. PubMed ID: 27832799
[TBL] [Abstract][Full Text] [Related]
35. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT.
Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC
Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226
[TBL] [Abstract][Full Text] [Related]
36. Long-term risks of secondary cancer for various whole and partial breast irradiation techniques.
Hoekstra N; Fleury E; Merino Lara TR; van der Baan P; Bahnerth A; Struik G; Hoogeman M; Pignol JP
Radiother Oncol; 2018 Sep; 128(3):428-433. PubMed ID: 29914648
[TBL] [Abstract][Full Text] [Related]
37. A framework for estimating radiation-related cancer risks in Japan from the 2011 Fukushima nuclear accident.
Walsh L; Zhang W; Shore RE; Auvinen A; Laurier D; Wakeford R; Jacob P; Gent N; Anspaugh LR; Schüz J; Kesminiene A; van Deventer E; Tritscher A; del Rosarion Pérez M
Radiat Res; 2014 Nov; 182(5):556-72. PubMed ID: 25251702
[TBL] [Abstract][Full Text] [Related]
38. The growing concern of radiation dose in paediatric dental and maxillofacial CBCT: an easy guide for daily practice.
Stratis A; Zhang G; Jacobs R; Bogaerts R; Bosmans H
Eur Radiol; 2019 Dec; 29(12):7009-7018. PubMed ID: 31264018
[TBL] [Abstract][Full Text] [Related]
39. Risk of developing radiogenic cancer following photon-beam radiotherapy for Graves' orbitopathy.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Med Phys; 2018 Oct; 45(10):4775-4782. PubMed ID: 30105825
[TBL] [Abstract][Full Text] [Related]
40. Estimation of Second Primary Cancer Risk After Treatment with Radioactive Iodine for Differentiated Thyroid Carcinoma.
Corrêa NL; de Sá LV; de Mello RC
Thyroid; 2017 Feb; 27(2):261-270. PubMed ID: 27762670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
